IGN Stock Overview
Provides genetic diagnostic solutions in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
HyEnergy S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł3.08 |
| 52 Week High | zł5.60 |
| 52 Week Low | zł1.65 |
| Beta | 1.27 |
| 1 Month Change | 4.05% |
| 3 Month Change | 6.21% |
| 1 Year Change | 35.09% |
| 3 Year Change | -72.50% |
| 5 Year Change | 30.51% |
| Change since IPO | -28.37% |
Recent News & Updates
Recent updates
Here's Why We Think Inno-Gene (WSE:IGN) Might Deserve Your Attention Today
Jul 25
Here's Why We Think Inno-Gene (WSE:IGN) Is Well Worth Watching
Apr 05Here's Why I Think Inno-Gene (WSE:IGN) Is An Interesting Stock
Dec 28Should You Be Adding Inno-Gene (WSE:IGN) To Your Watchlist Today?
Aug 28We Wouldn't Rely On Inno-Gene's (WSE:IGN) Statutory Earnings As A Guide
Feb 17
Shareholder Returns
| IGN | PL Life Sciences | PL Market | |
|---|---|---|---|
| 7D | 24.2% | 0.8% | 0.09% |
| 1Y | 35.1% | -22.4% | -2.8% |
Return vs Industry: IGN exceeded the Polish Life Sciences industry which returned -22.4% over the past year.
Return vs Market: IGN exceeded the Polish Market which returned -2.8% over the past year.
Price Volatility
| IGN volatility | |
|---|---|
| IGN Average Weekly Movement | 15.9% |
| Life Sciences Industry Average Movement | 7.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.9% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: IGN's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: IGN's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 8 | n/a | www.inno-gene.pl |
HyEnergy S.A. provides genetic diagnostic solutions in Poland. It is involved in the research and diagnostic center implementation; and the provision of technologies in the field of DNA analysis. The company also develops and implements diagnostic algorithm for prevention and personalization of treatment of HPV-dependent solid tumors.
HyEnergy S.A. Fundamentals Summary
| IGN fundamental statistics | |
|---|---|
| Market cap | zł103.43m |
| Earnings (TTM) | -zł5.89m |
| Revenue (TTM) | zł365.00k |
283.4x
P/S Ratio-17.6x
P/E RatioIs IGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IGN income statement (TTM) | |
|---|---|
| Revenue | zł365.00k |
| Cost of Revenue | zł681.00k |
| Gross Profit | -zł316.00k |
| Other Expenses | zł5.57m |
| Earnings | -zł5.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | -86.58% |
| Net Profit Margin | -1,613.42% |
| Debt/Equity Ratio | 31.0% |
How did IGN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 02:50 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HyEnergy S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |